A detailed history of Magnolia Capital Advisors LLC transactions in Amgen Inc stock. As of the latest transaction made, Magnolia Capital Advisors LLC holds 1,556 shares of AMGN stock, worth $491,696. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,556
Holding current value
$491,696
% of portfolio
0.02%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

BUY
$262.75 - $319.31 $408,839 - $496,846
1,556 New
1,556 $486,000
Q2 2021

Jul 29, 2021

SELL
$233.58 - $259.14 $818,697 - $908,285
-3,505 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$221.91 - $258.6 $529,033 - $616,502
2,384 Added 212.67%
3,505 $872,000
Q4 2020

Jan 29, 2021

BUY
$216.38 - $257.67 $190,630 - $227,007
881 Added 367.08%
1,121 $258,000
Q3 2020

Nov 02, 2020

SELL
$234.65 - $260.95 $165,428 - $183,969
-705 Reduced 74.6%
240 $240,000
Q3 2020

Nov 02, 2020

BUY
$234.65 - $260.95 $221,744 - $246,597
945 New
945 $240,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Magnolia Capital Advisors LLC Portfolio

Follow Magnolia Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Magnolia Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Magnolia Capital Advisors LLC with notifications on news.